These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 24556822)
1. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases. Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822 [TBL] [Abstract][Full Text] [Related]
3. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic. Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306 [TBL] [Abstract][Full Text] [Related]
4. The use of propranolol for complicated infantile hemangiomas. Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783 [TBL] [Abstract][Full Text] [Related]
5. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study. Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031 [TBL] [Abstract][Full Text] [Related]
6. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature. Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase. Vivas-Colmenares GV; Bernabeu-Wittel J; Alonso-Arroyo V; Matute de Cardenas JA; Fernandez-Pineda I Pediatr Dermatol; 2015; 32(3):348-52. PubMed ID: 25721095 [TBL] [Abstract][Full Text] [Related]
8. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases. Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227 [TBL] [Abstract][Full Text] [Related]
9. Retrospective study of the treatment of infantile hemangiomas using a combination of propranolol and pulsed dye laser. Reddy KK; Blei F; Brauer JA; Waner M; Anolik R; Bernstein L; Brightman L; Hale E; Karen J; Weiss E; Geronemus RG Dermatol Surg; 2013 Jun; 39(6):923-33. PubMed ID: 23458381 [TBL] [Abstract][Full Text] [Related]
10. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Buckmiller LM; Munson PD; Dyamenahalli U; Dai Y; Richter GT Laryngoscope; 2010 Apr; 120(4):676-81. PubMed ID: 20112413 [TBL] [Abstract][Full Text] [Related]
11. [Infantile hemangiomas: the revolution of beta-blockers]. Leaute-Labreze C Rev Prat; 2014 Dec; 64(10):1421-8. PubMed ID: 25665327 [TBL] [Abstract][Full Text] [Related]
12. Late rebound of infantile hemangioma after cessation of oral propranolol. Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283 [TBL] [Abstract][Full Text] [Related]
13. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients. Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601 [TBL] [Abstract][Full Text] [Related]
14. [Infantile hemangioma and propranolol: a therapeutic "revolution". Literature review]. Yilmaz L; Dangoisse C; Semaille P Rev Med Brux; 2013; 34(6):479-84. PubMed ID: 24505868 [TBL] [Abstract][Full Text] [Related]
15. Propranolol for infantile haemangioma: striking effect in the first weeks. Katona G; Csákányi Z; Gács E; Szalai Z; Ráth G; Gerlinger I Int J Pediatr Otorhinolaryngol; 2012 Dec; 76(12):1746-50. PubMed ID: 22944359 [TBL] [Abstract][Full Text] [Related]
16. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study. Yu Z; Cai R; Chang L; Qiu Y; Chen X; Chen Q; Ma G; Jin Y; Lin X J Dermatol; 2019 May; 46(5):376-382. PubMed ID: 30916822 [TBL] [Abstract][Full Text] [Related]
17. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study. Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454 [TBL] [Abstract][Full Text] [Related]
18. Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience. El Hachem M; Gesualdo F; Diociaiuti A; Berti I; Vercellino N; Boccaletti V; Neri I; Porcedda G; Greco A; Carnevale C; Oranges T; Cutrone M; Dalmonte P Ital J Pediatr; 2017 Apr; 43(1):40. PubMed ID: 28424095 [TBL] [Abstract][Full Text] [Related]
19. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study. Betlloch-Mas I; Martínez-Miravete MT; Lucas-Costa A; Martin de Lara AI; Selva-Otalaurruchi J Actas Dermosifiliogr; 2012 Nov; 103(9):806-15. PubMed ID: 22727954 [TBL] [Abstract][Full Text] [Related]
20. Factors associated with the relapse of infantile haemangiomas in children treated with oral propranolol. Ahogo CK; Ezzedine K; Prey S; Colona V; Diallo A; Boralevi F; Taïeb A; Léauté-Labrèze C Br J Dermatol; 2013 Dec; 169(6):1252-6. PubMed ID: 23662995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]